Literature DB >> 24272933

Concomitant Aspergillus Species Infection and Squamous Cell Carcinoma Diagnosed on Pap Smear.

Prajwala Gupta1, Snigdha Goyal, Manju Kaushal.   

Abstract

Concomitant infection with Aspergillus species and cervical squamous cell carcinoma in the female genital tract is a rare occurrence and attributed to the opportunistic nature of infection in the immunocompromised state due to the underlying malignancy. The contamination of smears with Aspergillus species should be excluded. The diagnosis of Aspergillus species infection along with squamous cell carcinoma was established on cervicovaginal pap smears in a 62-year-old female presented to gynecological clinic with complaints of stress urinary incontinence. Speculum examination revealed first-degree cervical descent. Smears showed features of squamous cell carcinoma along with fungal spores and fruiting body with hyphae of Aspergillus species. The presence of fruiting bodies and hyphae of Aspergillus species with coexisting squamous cell carcinoma is rare in routine pap smears. True infection needs to be distinguished from contamination by Aspergillus species. Early diagnosis can be established on routine cervicovaginal Pap smear examination.

Entities:  

Mesh:

Year:  2016        PMID: 24272933     DOI: 10.5146/tjpath.2013.01198

Source DB:  PubMed          Journal:  Turk Patoloji Derg        ISSN: 1018-5615


  2 in total

1.  Aspergillus in liquid-based cervicovaginal cytology in a postmenopausal patient: A case report.

Authors:  Raquel Garza-Guajardo; Luis Carlos Canales-Martínez; Irám Pablo Rodríguez-Sánchez; María Marisela Sánchez-Chaparro; Gabriela Sofía Gómez-Macías; Natalia Vilches-Cisneros; Oralia Barboza-Quintana
Journal:  Biomed Rep       Date:  2017-08-25

2.  Immunobiological Activity of Synthetically Prepared Immunodominant Galactomannosides Structurally Mimicking Aspergillus Galactomannan.

Authors:  Ema Paulovičová; Lucia Paulovičová; Martin Hrubiško; Vadim B Krylov; Dmitry A Argunov; Nikolay E Nifantiev
Journal:  Front Immunol       Date:  2017-10-13       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.